Clinical Trials in Tennessee

Showing 14741-14760 of 17,345 trials

AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy

NCT00372944

The purpose of this study is to assess the efficacy and safety of AZD6244 (ARRY-142886)versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line therapy with gemcitabine. Following baseline assessments, a minimum of 64 patients in approximately 5-6 centers from the US will be treated with either AZD6244 or capecitabine. Treatment will be continued for as long as the patients receive clinical benefit. The status of all patients will be checked (whether they are still taking treatment or not) approximately 3 months after the last patient has entered the study.

Pancreatic Cancer

AstraZeneca70 participantsStarted Aug 2006

Alhambra, California, United States • Bakersfield, California, United States • Palm Springs, California, United States +14 more locations

COMPLETEDPhase 229 miles

Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia

NCT00021242

RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of docetaxel in treating children who have relapsed or refractory acute lymphoblastic or acute myeloid leukemia.

Leukemia

Children's Oncology Group12 participantsStarted Aug 2002

Birmingham, Alabama, United States • Mobile, Alabama, United States • Phoenix, Arizona, United States +225 more locations

AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy

Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia

Find Trials by Condition in Tennessee

Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo

A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis

Study of Silodosin to Facilitate Passage of Urinary Stones

A Phase 3 Study of Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus (HCV)

A Study of Telaprevir (VX-950), Pegasys and Copegus in Hepatitis C (PROVE3)

Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors

NP2 Enkephalin For Treatment of Intractable Cancer Pain

The AttenueX IntraVesical System for the Treatment of Female Stress Urinary Incontinence

Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery

A Safety and Effectiveness Study of JNJ-18038683 in Patients With Moderate to Severe Depression

Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients

Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma

Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma

Heart Rate Changes in Subjects With Epilepsy

The CareFUL Prevention Trial

An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-tumor Necrosis Factor (TNF) Therapy

A Trial To Assess Safety And Tolerability Of PF-04691502 In Cancer Patients

A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema